Literature DB >> 1865159

Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.

P Reichard1, B Berglund, A Britz, I Cars, B Y Nilsson, U Rosenqvist.   

Abstract

Ninety-six patients with insulin-dependent diabetes mellitus (IDDM) and non-proliferative retinopathy were randomized to intensified conventional treatment (ICT) (n = 44) or regular treatment (RT) (n = 52), and followed up for 5 years. HbA1c decreased from 9.5 +/- 0.2% (mean value +/- SEM) to 7.2 +/- 0.1% in the ICT group, and from 9.4 +/- 0.2% to 8.7 +/- 0.1% in the RT group (difference between the groups, P less than 0.001). Retinopathy increased in both groups (P less than 0.001), but after 5 years it was worse in the RT group (P less than 0.05). The urinary albumin excretion rate was higher in the RT group than in the ICT group after 5 years (239.9 +/- 129.7 micrograms min-1 vs. 46.0 +/- 26.1 micrograms min-1, P less than 0.05). Eight RT patients developed manifest nephropathy, compared with none in the ICT group (P less than 0.01). After 5 years the conduction velocities of the sural (P less than 0.05), peroneal (P less than 0.01) and tibial (P less than 0.001) nerves were lower in the RT group. The respiratory sinus arrhythmia was 12.1 +/- 1.2 beats min-1 in the RT group and 16.7 +/- 1.4 beats min-1 in the ICT group at the end of the study (P less than 0.01). The increases in retinopathy (P less than 0.01), nephropathy (P less than 0.01) and neuropathy (P less than 0.001) were all related to the mean HbA1c value during the study. Smoking habits only influenced the progression of retinopathy (P less than 0.05). Serious hypoglycaemia occurred in 34 ICT patients and 29 RT patients (242 and 98 episodes, respectively) (P less than 0.05). Whereas weight was stable in the RT group, the body mass index increased by 5.8% in the ICT group (P less than 0.01). In conclusion, microvascular complications of diabetes were retarded by intensified conventional insulin treatment. However, such treatment increased the frequency of serious hypoglycaemia, and led to an increase in body weight.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865159     DOI: 10.1111/j.1365-2796.1991.tb00415.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  43 in total

Review 1.  Clinical evidence: glycaemic control in diabetes.

Authors:  W H Herman
Journal:  BMJ       Date:  1999-07-10

Review 2.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

3.  Time for "drilling down".

Authors:  Frank Vinicor
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

Review 4.  Role of self-monitoring of blood glucose in glycemic control.

Authors:  Andrew J Karter
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

5.  Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus.

Authors:  K Wikblad; J Leksell; L Wibell
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).

Authors: 
Journal:  Diabetologia       Date:  1998-04       Impact factor: 10.122

7.  Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Mamta Jaiswal; Tasha E Fingerlin; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Stephen R Daniels; Santica M Marcovina; Larry M Dolan; Dana Dabelea
Journal:  Diabetes Technol Ther       Date:  2013-09-06       Impact factor: 6.118

8.  In treating diabetes, what is important? Glucose levels or outcome measures?

Authors:  Anil K Mandal
Journal:  World J Diabetes       Date:  2015-10-10

9.  Tablet and insulin therapy in type 2 diabetes in the elderly.

Authors:  A H Barnett
Journal:  J R Soc Med       Date:  1994-10       Impact factor: 5.344

Review 10.  The long and winding road to optimal HbA1c measurement.

Authors:  Randie R Little; Curt L Rohlfing
Journal:  Clin Chim Acta       Date:  2013-01-11       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.